Nanobiotix SA (NAS:NBTX)
$ 4.6798 0.1798 (4%) Market Cap: 221.82 Mil Enterprise Value: 203.27 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Nanobiotix SA at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 01, 2022 / 02:15PM GMT
Release Date Price: $3.81 (-3.54%)
Jonathan Miller
Evercore ISI - Analyst

Good morning, everybody, and welcome to our final day of our healthcare conference here with Nanobiotix management team. Thank you guys so much for joining us today.

Laurent Levy
Nanobiotix S.A. - CEO

Thank you, nice to be here.

Questions & Answers

Jonathan Miller
Evercore ISI - Analyst

Before we jump into questions, maybe, Laurent, I'd love it if you gave us just a brief overview of where Nanobiotix is at in and what you view as the most important catalyst as we go into 2023.

Laurent Levy
Nanobiotix S.A. - CEO

Sure, but maybe in short term, short note like what Nanobiotix is doing is trying to change the outcome for many patients using nanophysics and within the realms of radiation therapy, which is a widely used tool in oncology. We've decided after our first proof of concept in a randomized Phase 3 in soft tissue sarcoma, it was positive to start building our franchise in head and neck cancer.

And that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot